Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-10-23 4:40 pm Purchase | 13G | RAPT THERAPEUTICS INC RAPT | Deep Track Capital LP | 1,991,403 5.8% | 1,991,403 (New Position) | View |
2023-10-02 4:32 pm Purchase | 13G | ANAPTYSBIO INC ANAB | Deep Track Capital LP | 1,360,176 5.12% | 1,360,176 (New Position) | View |
2023-09-29 4:15 pm Purchase | 13G | HILLEVAX INC HLVX | Deep Track Capital LP | 2,900,000 6.14% | 2,900,000 (New Position) | View |
2023-08-04 4:17 pm Purchase | 13G | EDITAS MEDICINE INC EDIT | Deep Track Capital LP | 4,493,416 5.51% | 4,493,416 (New Position) | View |
2023-07-28 4:25 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital LP | 3,560,000 6.28% | 3,560,000 (New Position) | View |
2023-07-24 4:05 pm Purchase | 13G | APOGEE THERAPEUTICS INC APGE | Deep Track Capital LP | 3,023,456 8.87% | 3,023,456 (New Position) | View |
2023-06-30 4:00 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Deep Track Capital LP | 7,258,056 9.99% | 7,258,056 (New Position) | View |
2023-06-15 4:02 pm Purchase | 13G | ZURA BIO LTD ZURA | Deep Track Capital LP | 4,205,000 9.39% | 4,205,000 (New Position) | View |
2023-05-19 4:23 pm Purchase | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | Deep Track Capital LP | 6,556,180 5.1% | 6,556,180 (New Position) | View |
2023-04-14 4:35 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | Deep Track Capital LP | 3,254,132 5.21% | 3,254,132 (New Position) | View |
2023-04-14 4:34 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital LP | 12,302,237 6.5% | 12,302,237 (New Position) | View |
2023-03-20 4:55 pm Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | Deep Track Capital LP | 3,104,507 5.27% | 3,104,507 (New Position) | View |
2023-03-20 4:43 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Deep Track Capital LP | 19,125,150 9.99% | 19,125,150 (New Position) | View |
2023-02-24 4:13 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 2,717,171 5.75% | 450,602 (+19.88%) | View |
2023-02-14 09:53 am Sale | 13G | KEROS THERAPEUTICS INC KROS | Deep Track Capital LP | 0 0% | -1,300,000 (Position Closed) | View |
2023-02-14 08:59 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital LP | 3,312,974 7.93% | 1,493,285 (+82.06%) | View |
2023-02-14 08:59 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 4,582,000 7.14% | 1,146,800 (+33.38%) | View |
2023-02-14 08:58 am Sale | 13G | TRICIDA INC TCDA | Deep Track Capital LP | 4,666,666 7.44% | -1,191,163 (-20.33%) | View |
2023-02-14 08:57 am Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 2,727,606 6.5% | 627,606 (+29.89%) | View |
2023-02-14 08:56 am Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | Deep Track Capital LP | 2,837,818 9.43% | 356,818 (+14.38%) | View |